Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Will Seek Out More R&D Opportunities in Korea

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Pfizer Korea will seek more opportunities for R&D partnerships in Korea as it tries to develop treatments for Asia-prevalent liver and stomach cancers
Advertisement

Related Content

MNC Products Retain Dominance In Korea As Local Generics Face Challenges
MNC Products Retain Dominance In Korea As Local Generics Face Challenges
Pfizer Korea Builds Up Presence Further In Korea Through Merger With Wyeth Korea
Pfizer Korea Builds Up Presence Further In Korea Through Merger With Wyeth Korea
Pfizer Korea Signs Development Pact With State KRIBB For Liver and Gastric Cancer Drugs
Advertisement
UsernamePublicRestriction

Register

SC074527

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel